Bronk Harms

Senior Director, U.S. Sales and Strategic Accounts at Cerus

Denver, CO


Office Hours

How does this work?

Summary of Qualifications -Proven track record of leading sales teams to the top tier of the sales organization -Highly professional, hard-working sales leader -Experience selling in the corporate accounts setting and knowledge of the GPO sales process -Strong communication and relationship building skills with all levels of medical professionals -Goal achieving self-starter -Focused, persistent, and competitive -10+ years of documented sales results leading to successful financial growth in the medical industry -Strategic, creative thinker comfortable taking calculated risks Professional Skills Business Strengths: Determined; reliable; aptitude for assessing and motivating people; holds others accountable; efficient in problem solving and statistical analysis; strong presentation, public speaking, and coaching skills; goal-oriented; proven leader and team player Specialties: adobe photoshop, adobe pagemaker, computer skills, illustrator, market planning, marketing, microsoft access, microsoft office, microsoft windows, presentation skills, sales training, business planning

Ask me about
Cardiac Monitoring
Sales Enablement Software
digital strategy
Work experience

Mar 2020 - Present


Senior Director, U.S. Sales and Strategic Accounts

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Based in Concord, California, our employees are committed to deploy and supply vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who deserve on safe blood. The INTERCEPT® Blood System for Platelets and Plasma Pathogen Reduction System inactivates bacteria, viruses, emerging pathogens, parasites and leucocytes in blood products prior to transfusion. INTERCEPT® is FDA and CE Mark approved to reduce the risk of transfusion-transmitted infection (TTI), including sepsis, and as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD).1* INTERCEPT® pathogen reduction has also been included in multiple FDA Guidance’s to mitigate bacteria, babesia and Zika. Pathogen reduction is cited by the American Association of Blood Banks (AABB) as meeting standards to prevent TA-GVHD as an alternative to irradiation. The robust inactivation of CMV by INTERCEPT technology also meets the AABB CMV mitigation standards. Cerus currently supplies the INTERCEPT® Blood System in the United States, Europe, the Commonwealth of Independent States, the Middle East, and selected countries in other regions around the world. The INTERCEPT® Cryoprecipitate and Red Blood Cell systems are in clinical development. *There is no pathogen inactivation process that has been shown to eliminate all pathogens. Certain non-enveloped viruses (e.g., HAV, HEV, B19, and poliovirus) and Bacillus cereus spores have demonstrated resistance to the psoralen/UVA light process. 1. The INTERCEPT Blood System for Platelets Package Insert, Cerus Corporation; July 17, 2018.


Jul 2019 - Mar 2020

iRhythm Technologies, Inc.

Regional Sales Director

Oct 2017 - Jul 2019

Sonendo®, Inc.

Area Sales Director

Responsible for the sales and adoption of the GentleWave Technology in the Sound Central Region. Achieved President's Club in 2018, finishing 260% to quota.


Sep 2011 - Sep 2017


Regional Business Manager

Responsible for leading the Northwest Peripheral Vascular sales team and driving growth in an emerging, regional markets for a market leader in vascular access, peripheral intervention, and interventional oncology devices. Directly accountable for performance and professional development of a nine member of team. Mentor and coach charged with creating team cohesion and managing the accomplishment of the region's near-to-long term sales objectives. FY2013 - Finished #4 of 15 regions nationally and #1 in the Western Zone


Apr 2010 - Aug 2011


Corporate Accounts Manager


Feb 2006 - Mar 2010


Senior Sales Representative

Promoted in June 2009; Identify market opportunities and challenges to subsequently develop, plan, implement, and follow through with action plans to positively influence territory business partnerships Develop and maintain relationships with all practitioners in the Baltimore/Washington, D.C. area Increase sales opportunities of both capital and disposable equipment in the Operating Room, Cath Lab, and Interventional Suite Proctor cases with physicians to increase usage of AngioDynamics products and develop local thought leaders to endorse AngioDynamics products Train new representatives ensuring product knowledge and business acumen to promote success within AngioDynamics

Jul 2005 - Feb 2006

Covidien (Medtronic Minimally Invasive Therapies Group)

Field Sales Trainer

Responsible for the sales representative product and clinical knowledge and presentation skills Develop opportunities to promote growth and confidence for new sales representatives Trained nine sales representatives on products and five on computer applications in 2005 Extensive training in GPO/contract selling and focused on partnership selling in hospitals

Dec 2004 - Feb 2006

Covidien (Medtronic Minimally Invasive Therapies Group)

Account Representative

Responsible for over $5.5 million in sales in the Washington D.C. territory Finished 104% to quota for 2006; third in nation Awarded Mid-Atlantic Region Rep of the Month four times in 2005 Awarded Mid-Atlantic Region Rep of the Year in 2005 Awarded Masters Training Award for Kendall Patient Care (Finished #1 in training class)

Jan 2003 - Dec 2004

Eli Lilly and Company

Pharmaceutical Sales Representative

Promoted the use of existing portfolio of products to targeted physicians and medical staff Analyzed market conditions and develop new marketing strategies to increase sales Was responsible for accounts with key OB/GYNs, Endocrinologists, Internists, and Urologists Achieved sales in territory of over $1.2 million in 2003 Conducted injection training classes for staff and physicians for Forteo, a bone-forming injectable


1998 - 2002

B.S., Marketing and International Business


International Business

Talk to Bronk

@ Copyright 2020 OfficeHours Technologies Co.